trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Truong M et al. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. 2012 Br. J. Cancer pmid:22596233
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Zhang L et al. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. 2012 J. Biol. Chem. pmid:23024362
Chen H et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. 2012 Cancer Lett. pmid:22743615
Qin ZX et al. [Effect of TSA and VPA treatment on long-tailed macaque (Macaca fascicularis)-pig interspecies somatic cell nuclear transfer]. 2012 Yi Chuan pmid:22425953
Zhu S et al. TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells. 2012 J. Cell. Biochem. pmid:22388778
Usui T et al. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22389387
Mostovich LA et al. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. 2011 Sep-Oct Cell Adh Migr pmid:21975548
Stepanek I et al. Effects of 5-azacytidine and trichostatin A on dendritic cell maturation. 2011 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:22217985
Kee HJ et al. Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4. 2011 Nov-Dec Vascul. Pharmacol. pmid:21763782
Meng CF et al. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells. 2011 Nov-Dec Mol Med Rep pmid:21850374
Cowell IG et al. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin. 2011 Jan-Feb Nucleus pmid:21647300
Arany I et al. Epigenetic modifiers exert renal toxicity through induction of p66shc. 2011 Anticancer Res. pmid:21965735
Sasaki Y et al. p53 negatively regulates the hepatoma growth factor HDGF. 2011 Cancer Res. pmid:22006999
Aoyama K et al. Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. 2011 Exp. Cell Res. pmid:22001646
Hirata H et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. 2011 Int. J. Cancer pmid:20549706
Hagiwara H et al. Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. 2011 Biochem. Biophys. Res. Commun. pmid:22019851
Jafari S et al. Epigenetic modification does not determine the time of POU5F1 transcription activation in cloned bovine embryos. 2011 J. Assist. Reprod. Genet. pmid:22020531
Tseng AS et al. HDAC activity is required during Xenopus tail regeneration. 2011 PLoS ONE pmid:22022609
Rajak H et al. 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21875796
He HM et al. [The effects of a histone deacetylase (HDAC) inhibitor on endotoxin-induced endothelial cell injury]. 2011 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:22005560
Sanders YY et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. 2011 Am. J. Respir. Cell Mol. Biol. pmid:20724553
Xia B et al. Chromium(VI) causes down regulation of biotinidase in human bronchial epithelial cells by modifications of histone acetylation. 2011 Toxicol. Lett. pmid:21641978
Seo SK et al. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. 2011 J Thorac Oncol pmid:21642861
Acun T et al. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation. 2011 BMC Cancer pmid:21645397
Hou J et al. Structure-based optimization of click-based histone deacetylase inhibitors. 2011 Eur J Med Chem pmid:21621883
Gaub P et al. The histone acetyltransferase p300 promotes intrinsic axonal regeneration. 2011 Brain pmid:21705428
Song K et al. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer. 2011 Cancer Biol. Ther. pmid:21709440
Hauff KD et al. Mifepristone treatment results in differential regulation of glycerolipid biosynthesis in baby hamster kidney cells expressing a mifepristone-inducible ABCA1. 2011 Lipids pmid:21710238
Zhou S et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. 2011 Circ. Res. pmid:21778425
Yoo YE and Ko CP Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. 2011 Exp. Neurol. pmid:21712032
Sar P et al. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. 2011 PLoS ONE pmid:21687737
Cosner CC and Helquist P Concise, convergent syntheses of (±)-trichostatin A utilizing a Pd-catalyzed ketone enolate α-alkenylation reaction. 2011 Org. Lett. pmid:21688856
Kojima S et al. Asymmetric leaves2 and Elongator, a histone acetyltransferase complex, mediate the establishment of polarity in leaves of Arabidopsis thaliana. 2011 Plant Cell Physiol. pmid:21700721
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Zhang L et al. ABA treatment of germinating maize seeds induces VP1 gene expression and selective promoter-associated histone acetylation. 2011 Physiol Plant pmid:21679193
Lin S et al. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. 2011 Curr. HIV Res. pmid:21631428
Li Z et al. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines. 2011 Cell Biol. Int. pmid:21314642
Saiyed ZM et al. HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). 2011 Neurochem. Int. pmid:21315782
Fang Y et al. Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341. 2011 Cancer Invest. pmid:21345073
Qian Y et al. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation. 2011 J. Biol. Chem. pmid:21317427
Zhang F et al. Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis. 2011 PLoS ONE pmid:21346816
Hizaki K et al. Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. 2011 Mod. Pathol. pmid:21317879
Zhou X et al. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice. 2011 J. Clin. Immunol. pmid:21305388
Meli M et al. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. 2011 Int. J. Oncol. pmid:21318222
Turovets N et al. Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment. 2011 Differentiation pmid:21306817
Xiao J et al. Discovery, synthesis, and biological evaluation of novel SMN protein modulators. 2011 J. Med. Chem. pmid:21819082
Yang H et al. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. 2011 Hepatology pmid:21319187
Patel T et al. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice. 2011 Immunol. Cell Biol. pmid:21321581
Chaurasia P et al. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. 2011 Blood pmid:21355088
Shi G et al. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells. 2011 J. Cell. Physiol. pmid:21321941
Furuta K et al. The CKH2/PKL chromatin remodeling factor negatively regulates cytokinin responses in Arabidopsis calli. 2011 Plant Cell Physiol. pmid:21357580
Fan Y et al. Derivation of cloned human blastocysts by histone deacetylase inhibitor treatment after somatic cell nuclear transfer with β-thalassemia fibroblasts. 2011 Stem Cells Dev. pmid:21322785
Kim YJ et al. Comparison of potency between histone deacetylase inhibitors trichostatin A and valproic acid on enhancing in vitro development of porcine somatic cell nuclear transfer embryos. 2011 In Vitro Cell. Dev. Biol. Anim. pmid:21359816
Jang ER et al. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines. 2011 Mol. Cell. Biochem. pmid:21380726
Fan T et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. 2011 Mol. Cancer Res. pmid:21383005
Yang J et al. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21473137
Cui XS et al. Trichostatin A modulates apoptotic-related gene expression and improves embryo viability in cloned bovine embryos. 2011 Cell Reprogram pmid:21473694
Chen X et al. Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents. 2011 Molecules pmid:22048700
Sun JY et al. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia. 2011 Clin Lymphoma Myeloma Leuk pmid:21454220
Kong QR et al. [TSA improve transgenic porcine cloned embryo development and transgene expression]. 2011 Yi Chuan pmid:22049689
Dávalos-Salas M et al. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter. 2011 BMC Cancer pmid:21663659
El-Serafi AT et al. Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. 2011 Differentiation pmid:20970916
Zhang FQ et al. Cell-cycle-dependent variations in the FTIR spectroscopy of HeLa cells treated with trichostatin A. 2011 Guang Pu Xue Yu Guang Pu Fen Xi pmid:22007388
Nagamine MK et al. In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor. 2011 Vet. Res. Commun. pmid:21472452
Maruoka H et al. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. 2011 J. Biochem. pmid:21908547
Biermann J et al. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. 2011 Mol. Vis. pmid:21311741
Li S et al. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. 2011 Mol. Cancer pmid:21314984
Pang M et al. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. 2011 J. Cell. Biochem. pmid:21465537
Kimura T et al. Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300. 2011 J Toxicol Sci pmid:21467744
Zhang CZ et al. Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. 2011 Apoptosis pmid:21468663
Hu Y et al. Trichostatin A selectively suppresses the cold-induced transcription of the ZmDREB1 gene in maize. 2011 PLoS ONE pmid:21811564
Chen YT et al. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy. 2011 Spine pmid:21343850
Lee MJ et al. Trichostatin A promotes the development of bovine somatic cell nuclear transfer embryos. 2011 J. Reprod. Dev. pmid:20834196
Amoêdo ND et al. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors. 2011 PLoS ONE pmid:21789245
Sengupta S et al. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. 2011 Oncogene pmid:20856196
Arzenani MK et al. Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics. 2011 Mol. Cell. Biol. pmid:21791605
Costa VL et al. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. 2011 Epigenetics pmid:21847011
Akagi S et al. Treatment with a histone deacetylase inhibitor after nuclear transfer improves the preimplantation development of cloned bovine embryos. 2011 J. Reprod. Dev. pmid:20962457
Fu S et al. Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. 2011 PLoS ONE pmid:22132182
Mayor R et al. Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. 2011 Epigenetics pmid:21852760
Kumar A et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. 2011 Int. J. Radiat. Biol. pmid:21815748
Tan L et al. Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. 2011 Cancer pmid:20925046
Jackson K et al. Epigenetic silencing of somatostatin in gastric cancer. 2011 Dig. Dis. Sci. pmid:20927589
Sahu GK and Cloyd MW Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. 2011 Virol. J. pmid:21838863
Yu D et al. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. 2011 Bioorg. Med. Chem. Lett. pmid:21840716
Hai T et al. Pluripotency maintenance in mouse somatic cell nuclear transfer embryos and its improvement by treatment with the histone deacetylase inhibitor TSA. 2011 Cell Reprogram pmid:21241188
Nakamura J et al. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. 2011 Am. J. Pathol. pmid:21281785
Puppin C et al. In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. 2011 Cell Oncol (Dordr) pmid:21290209
Ishiguro K et al. Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interaction. 2011 J. Immunol. pmid:21278340
Ma AN et al. Histone deacetylation directs DNA methylation in survivin gene silencing. 2011 Biochem. Biophys. Res. Commun. pmid:21130077
Pianta A et al. Nucleophosmin delocalization in thyroid tumour cells. 2011 Endocr. Pathol. pmid:21258971
Gómez MC et al. Trichostatin A modified histone covalent pattern and enhanced expression of pluripotent genes in interspecies black-footed cat cloned embryos but did not improve in vitro and in vivo viability. 2011 Cell Reprogram pmid:21718106
Whitehead L et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. 2011 Bioorg. Med. Chem. pmid:21723733
Yin H et al. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells. 2011 Mol. Biol. Rep. pmid:21181272
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Puppin C et al. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. 2011 Oncol. Rep. pmid:21152868
Tsai PF et al. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. 2011 J. Virol. pmid:21159880
Misaki K et al. Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice. 2011 Arthritis Res. Ther. pmid:21592365
Selinger CI et al. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. 2011 J Thorac Oncol pmid:21597389